文献速递肝病消化道肿瘤与早癌

肝脏抑制素1与甲硫氨酸腺苷转移酶α1防御原发性和继发性肝癌转移

Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis.
PubMed 文献 · J Hepatol · 2023-12-10

本研究探讨肝脏高表达的抑制素1(PHB1)和甲硫氨酸腺苷转移酶1A(MAT1A)在原发性和继发性肝癌转移中的作用。研究发现MMP-7是两者共同靶基因,PHB1/MAT1A通过AP-1位点抑制MAFG-FOSB复合物负调控MMP7启动子活性;两者缺失通过MMP-7诱导使肝脏对结直肠癌肝转移敏感。

要点

  • PHB1和MAT1A相互正调控,共同靶基因为MMP-7。
  • PHB1/MAT1A通过AP-1位点抑制MAFG-FOSB复合物负调控MMP7启动子。
  • 肝脏MAT1A或PHB1低表达使小鼠对结直肠癌肝转移敏感,敲低内源性MMP-7可逆转。

核心结论

  • 研究确定了PHB1/MAT1A-MAFG/FOSB-MMP-7轴调控原发性肝癌转移及对结直肠癌肝转移的敏感性。
  • 靶向PHB1/MAT1A-MMP-7轴的策略可能是有前途的治疗原发性和继发性肝癌转移的方法。

研究设计与样本

  • 使用转移阵列鉴定PHB1和MAT1A的共同靶基因。
  • 采用荧光素酶报告基因实验检测启动子活性,染色质免疫沉淀检测转录因子结合。
  • 研究PHB1或MAT1A缺失如何促进肝癌转移及是否增加对结直肠癌肝转移的敏感性。

主要发现

  • MMP-7是MAT1A和PHB1的共同靶基因,MAT1A或PHB1沉默时其诱导导致迁移和侵袭增加。
  • PHB1和MAT1A通过AP-1位点抑制MAFG-FOSB复合物负调控MMP7启动子活性。
  • MAT1A或PHB1缺失还增加细胞外囊泡中的MMP-7,被结肠和胰腺癌细胞内化后增强其致癌性。
  • 肝脏MAT1A或PHB1低表达使小鼠对结直肠癌肝转移敏感,但先敲低内源性肝脏MMP-7则不敏感,且肿瘤微环境中CD4+ T细胞降低而CD8+ T细胞增加。
  • 与结直肠癌细胞共培养的肝细胞MAT1A/PHB1表达降低而MMP-7表达升高;在小鼠和人类中,结直肠癌肝转移使远处肝细胞MMP-7表达升高。

临床怎么用

  • 原文结论提出靶向PHB1/MAT1A-MMP-7轴的策略可能是有前途的治疗原发性和继发性肝癌转移的方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The liver is a common site of cancer metastasis, most commonly from colorectal cancer, and primary liver cancers that have metastasized are associated with poor outcomes. The underlying mechanisms by which the liver defends against these processes are largely unknown. Prohibitin 1 (PHB1) and methionine adenosyltransferase 1A (MAT1A) are highly expressed in the liver. They positively regulate each other and their deletion results in primary liver cancer. Here we investigated their roles in primary and secondary liver cancer metastasis. METHODS: We identified common target genes of PHB1 and MAT1A using a metastasis array, and measured promoter activity and transcription factor binding using luciferase reporter assays and chromatin immunoprecipitation, respectively. We examined how PHB1 or MAT1A loss promotes liver cancer metastasis and whether their loss sensitizes to colorectal liver metastasis (CRLM). RESULTS: Matrix metalloproteinase-7 (MMP-7) is a common target of MAT1A and PHB1 and its induction is responsible for increased migration and invasion when MAT1A or PHB1 is silenced. Mechanistically, PHB1 and MAT1A negatively regulate MMP7 promoter activity via an AP-1 site by repressing the MAFG-FOSB complex. Loss of MAT1A or PHB1 also increased MMP-7 in extracellular vesicles, which were internalized by colon and pancreatic cancer cells to enhance their oncogenicity. Low hepatic MAT1A or PHB1 expression sensitized to CRLM, but not if endogenous hepatic MMP-7 was knocked down first, which lowered CD4+ T cells while increasing CD8+ T cells in the tumor microenvironment. Hepatocytes co-cultured with colorectal cancer cells express less MAT1A/PHB1 but more MMP-7. Consistently, CRLM raised distant hepatocytes' MMP-7 expression in mice and humans. CONCLUSION: We have identified a PHB1/MAT1A-MAFG/FOSB-MMP-7 axis that controls primary liver cancer metastasis and sensitization to CRLM. IMPACT AND IMPLICATIONS: Primary and secondary liver cancer metastasis is associated with poor outcomes but whether the liver has underlying defense mechanism(s) against metastasis is unknown. Here we examined the hypothesis that hepatic prohibitin 1 (PHB1) and methionine adenosyltransferase 1A (MAT1A) cooperate to defend the liver against metastasis. Our studies found PHB1 and MAT1A form a complex that suppresses matrix metalloproteinase-7 (MMP-7) at the transcriptional level and loss of either PHB1 or MAT1A sensitizes the liver to metastasis via MMP-7 induction. Strategies that target the PHB1/MAT1A-MMP-7 axis may be a promising approach for the treatment of primary and secondary liver cancer metastasis.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Fan W, Cao D, Yang B, et al. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis. J Hepatol. 2023. PMID: 38086446. doi:10.1016/j.jhep.2023.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。